Suppression of insulin-like growth factor acid-labile subunit expression--a novel mechanism for deoxynivalenol-induced growth retardation
about
Food chain mycotoxin exposure, gut health, and impaired growth: a conceptual frameworkEvaluation of insulin-like growth factor acid-labile subunit as a potential biomarker of effect for deoxynivalenol-induced proinflammatory cytokine expressionBody composition and hormonal effects following exposure to mycotoxin deoxynivalenol in the high-fat diet-induced obese mouse.Aflatoxin exposure is inversely associated with IGF1 and IGFBP3 levels in vitro and in Kenyan schoolchildrenAssessment of deoxynivalenol metabolite profiles in UK adultsCharacterization of deoxynivalenol-induced anorexia using mouse bioassay.Deoxynivalenol-induced proinflammatory gene expression: mechanisms and pathological sequelae.A biomarker survey of urinary deoxynivalenol in China: the Shanghai Women's Health Study.Growth performance, serum biochemical profile, jejunal morphology, and the expression of nutrients transporter genes in deoxynivalenol (DON)- challenged growing pigsDeoxynivalenol Impairs Weight Gain and Affects Markers of Gut Health after Low-Dose, Short-Term Exposure of Growing PigsMurine Anorectic Response to Deoxynivalenol (Vomitoxin) Is Sex-Dependent.The Potential Role of Mycotoxins as a Contributor to Stunting in the SHINE Trial.Anorexia induction by the trichothecene deoxynivalenol (vomitoxin) is mediated by the release of the gut satiety hormone peptide YYDevelopment and evaluation of a sensitive mycotoxin risk assessment model (MYCORAM).The role of biomarkers in evaluating human health concerns from fungal contaminants in food.From the gut to the brain: journey and pathophysiological effects of the food-associated trichothecene mycotoxin deoxynivalenol.Integrated Transcriptional and Proteomic Analysis of Growth Hormone Suppression Mediated by Trichothecene T-2 Toxin in Rat GH3 Cells.Influence of temperature and pH on the degradation of deoxynivalenol (DON) in aqueous medium: comparative cytotoxicity of DON and degraded product.JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults.Risks to human and animal health related to the presence of deoxynivalenol and its acetylated and modified forms in food and feedNitric oxide mediates apoptosis and mitochondrial dysfunction and plays a role in growth hormone deficiency by nivalenol in GH3 cells.Effects of deoxynivalenol consumption on body weight and adiposity in the diet-induced obese mouse.Deoxynivalenol exposure assessment in a cohort of pregnant women from Bradford, UK.Alleviation of mycotoxin biodegradation agent on zearalenone and deoxynivalenol toxicosis in immature gilts.Mycotoxins: cytotoxicity and biotransformation in animal cellsClimate change impacts on mycotoxin risks in US maize
P2860
Q27003457-F6095062-7EFB-4232-9F2C-7E4B79808177Q33697732-3CA56E0B-0743-4FA2-AE8A-F999984A656AQ33697738-C350596E-C19D-476D-B17C-7FD89332560BQ33953295-1B2FD05A-2C30-4755-83BD-37D89080C279Q34440893-A9F4A73D-0B01-420D-9B3A-F98C0F0162D4Q35070893-21243555-94B8-4765-9145-D8BE41CFFC52Q35155832-FC047829-BC44-4F07-A4D0-838DC8B69840Q35209582-C9AE2696-B025-465A-AC81-1353FCECE9CAQ35681711-789A06F7-798B-433D-B80C-67AB3FE64035Q35808575-3885B32D-6473-4CA3-9581-AABD73B5152CQ35996593-4B928AD4-14DB-4B6F-979A-CC191817D82BQ36311606-9076CB09-95B4-49E4-AE1A-218076EBDCA0Q36752713-A13AD5B6-CE8A-4353-8412-0B9EF6D60849Q36801696-C147543C-42AB-4538-BA54-A9192561FF7AQ38014991-5D67882A-859D-45E1-94CA-8557B7D5AF17Q38101247-F4E739C3-F769-4701-BC8E-2F5BD78FE9EEQ38856881-E8D29216-8521-40CB-8DA7-DE24146A6FDAQ39059345-BEBDC346-2D5B-4C33-92CA-C71665CE6D7DQ39372865-8EFC6467-85F5-4A06-9D35-06C20920231EQ43007757-4688133D-F3AD-48C7-872E-A25349E9700FQ47160469-8CFD62D8-7731-491A-BE1F-0BA415DCEAF3Q47161667-23D18AFB-AD98-443E-B2BE-4027AC310BF2Q47384909-6BFFE554-A61E-4F62-9411-B966D7BCA15BQ52845894-4FFB7038-E117-48C9-AA69-A5C7646DCBAFQ55032326-5D9CD379-A4FC-451C-A737-9F88DC1BD15CQ55110792-871E7DF3-7A9C-400C-9F8A-1351C3C2271EQ57436926-C8C42821-6BC5-48B3-AAF8-36FDDDC18160
P2860
Suppression of insulin-like growth factor acid-labile subunit expression--a novel mechanism for deoxynivalenol-induced growth retardation
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Suppression of insulin-like gr ...... nol-induced growth retardation
@ast
Suppression of insulin-like gr ...... nol-induced growth retardation
@en
type
label
Suppression of insulin-like gr ...... nol-induced growth retardation
@ast
Suppression of insulin-like gr ...... nol-induced growth retardation
@en
prefLabel
Suppression of insulin-like gr ...... nol-induced growth retardation
@ast
Suppression of insulin-like gr ...... nol-induced growth retardation
@en
P2860
P356
P1476
Suppression of insulin-like gr ...... nol-induced growth retardation
@en
P2093
Chidozie J Amuzie
James J Pestka
P2860
P304
P356
10.1093/TOXSCI/KFP225
P577
2009-10-04T00:00:00Z